The Syneos Health Podcast
152 Odcinki
-
Payer Power, Part 3
Opublikowany: 15.07.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 12: COVID-19 and Children
Opublikowany: 19.06.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 11: Rare Disease Clinical Trials and COVID-19
Opublikowany: 2.06.2020 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Yelp Ratings for Clinical Trials
Opublikowany: 27.05.2020 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Taming the Healthcare Data Explosion
Opublikowany: 15.05.2020 -
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Real World Data for Clinical Innovation
Opublikowany: 8.05.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 10: Ventilating the COVID-19 Patient
Opublikowany: 5.05.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 9: Telemedicine in the Age of COVID-19
Opublikowany: 23.04.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 8: Payers and COVID-19
Opublikowany: 16.04.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 7: Continuity in Clinical Trials
Opublikowany: 2.04.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 6: The Leader's Experience
Opublikowany: 30.03.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 5: Surviving the Ventilator Shortage
Opublikowany: 24.03.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 4: Clinical Trials Through Pandemics
Opublikowany: 24.03.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 3: Virtual Clinical Trials
Opublikowany: 20.03.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 2: The Clinical Experience
Opublikowany: 17.03.2020 -
CORONAVIRUS SPECIAL EDITION, Episode 1: The Personal Experience
Opublikowany: 13.03.2020 -
Recruiting Patients for Clinical Trials
Opublikowany: 6.03.2020 -
Medical Affairs Series, Part Six: Commercial Plus Medical Affairs
Opublikowany: 19.02.2020 -
2020 Health Trends: Box Store Healthcare
Opublikowany: 5.02.2020 -
Denials, Delays and Deep Discounts in Pharmaceutical Launch
Opublikowany: 24.01.2020
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.
